These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20041879)

  • 1. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
    O'Brien D; Chunduri P; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    Chan V; Hoey A; Brown L
    Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A; Fenning A; Levick S; Hoey A; Brown L
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
    Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
    Loch D; Levick S; Hoey A; Brown L
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
    Loch D; Hoey A; Brown L
    Clin Exp Hypertens; 2006 Jul; 28(5):475-88. PubMed ID: 16820344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
    Chan V; Fenning A; Iyer A; Hoey A; Brown L
    Curr Pharm Biotechnol; 2011 Mar; 12(3):429-36. PubMed ID: 20874677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
    Mirkovic S; Seymour AM; Fenning A; Strachan A; Margolin SB; Taylor SM; Brown L
    Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
    J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats.
    Fenning A; Harrison G; Rose'meyer R; Hoey A; Brown L
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1408-16. PubMed ID: 15923320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible correlation between the correction of endothelial dysfunction and normalization of high blood pressure levels by 1,3,4-oxadiazole derivative, an L-type Ca2+ channel blocker in deoxycorticosterone acetate and N(G)-nitro-l-arginine hypertensive rats.
    Bankar GR; Nampurath GK; Nayak PG; Bhattacharya S
    Chem Biol Interact; 2010 Jan; 183(2):327-31. PubMed ID: 19912999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
    Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
    Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.